Search research articles
Contact Us
Filters
Showing results (1-10 of 13) with videos related to
Page
of 2
Sort By:
Frontiers in Cardiovascular Medicine
|
June 20, 2022
Pulmonary Vasculature Responsiveness to Phosphodiesterase-5A Inhibition in Heart Failure With Reduced Ejection Fraction: Possible Role of Plasma Potassium
Luca Monzo, Adrian Reichenbach, Hikmet Al-Hiti, et al.
International Journal of Cardiology
|
October 13, 2012
The effects of phosphodiesterase 5 inhibition on hemodynamics, functional status and survival in advanced heart failure and pulmonary hypertension: a case-control study
Adrian Reichenbach, Hikmet Al-Hiti, Ivan Malek, et al.
Journal of the American College of Cardiology
|
August 8, 2009
Transpulmonary B-type natriuretic peptide uptake and cyclic guanosine monophosphate release in heart failure and pulmonary hypertension: the effects of sildenafil
Vojtech Melenovsky, Hikmet Al-Hiti, Ludmila Kazdova, et al.
The European Respiratory Journal
|
February 14, 2018
Macitentan in pulmonary hypertension due to left ventricular dysfunction
Jean-Luc Vachiéry, Marion Delcroix, Hikmet Al-Hiti, et al.
Journal of Cardiac Failure
|
November 24, 2020
Acute Unloading Effects of Sildenafil Enhance Right Ventricular-Pulmonary Artery Coupling in Heart Failure
Luca Monzo, Adrian Reichenbach, Hikmet Al-Hiti, et al.
International Journal of Cardiology
|
February 15, 2014
Long-term results from the EARLY study of bosentan in WHO functional class II pulmonary arterial hypertension patients
Gérald Simonneau, Nazzareno Galiè, Pavel Jansa, et al.
Circulation. Heart Failure
|
September 23, 2025
Transpulmonary Proteome Gradients Identify Pathways Involved in Pulmonary Vascular Disease Due To Heart Failure
Vojtech Melenovsky, Petr Jarolim, Eva Kutilkova, et al.
BMC Pulmonary Medicine
|
March 18, 2014
Epidemiology and long-term survival of pulmonary arterial hypertension in the Czech Republic: a retrospective analysis of a nationwide registry
Pavel Jansa, Jiri Jarkovsky, Hikmet Al-Hiti, et al.
The European Respiratory Journal
|
June 27, 2015
Bosentan added to sildenafil therapy in patients with pulmonary arterial hypertension
Vallerie McLaughlin, Richard N Channick, Hossein-Ardeschir Ghofrani, et al.
Pulmonary Circulation
|
August 18, 2025
Predicting Response to Switching From Phosphodiesterase Type 5 Inhibitor to Riociguat in Patients With Pulmonary Arterial Hypertension: Biomarker and Responder Analysis of the RESPITE and REPLACE Studies
James R Klinger, Hikmet Al-Hiti, Sung-A Chang, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 13) with videos related to
Sort By:
Page
of 2
Frontiers in Cardiovascular Medicine
|
June 20, 2022
Pulmonary Vasculature Responsiveness to Phosphodiesterase-5A Inhibition in Heart Failure With Reduced Ejection Fraction: Possible Role of Plasma Potassium
Luca Monzo, Adrian Reichenbach, Hikmet Al-Hiti, et al.
International Journal of Cardiology
|
October 13, 2012
The effects of phosphodiesterase 5 inhibition on hemodynamics, functional status and survival in advanced heart failure and pulmonary hypertension: a case-control study
Adrian Reichenbach, Hikmet Al-Hiti, Ivan Malek, et al.
Journal of the American College of Cardiology
|
August 8, 2009
Transpulmonary B-type natriuretic peptide uptake and cyclic guanosine monophosphate release in heart failure and pulmonary hypertension: the effects of sildenafil
Vojtech Melenovsky, Hikmet Al-Hiti, Ludmila Kazdova, et al.
The European Respiratory Journal
|
February 14, 2018
Macitentan in pulmonary hypertension due to left ventricular dysfunction
Jean-Luc Vachiéry, Marion Delcroix, Hikmet Al-Hiti, et al.
Journal of Cardiac Failure
|
November 24, 2020
Acute Unloading Effects of Sildenafil Enhance Right Ventricular-Pulmonary Artery Coupling in Heart Failure
Luca Monzo, Adrian Reichenbach, Hikmet Al-Hiti, et al.
International Journal of Cardiology
|
February 15, 2014
Long-term results from the EARLY study of bosentan in WHO functional class II pulmonary arterial hypertension patients
Gérald Simonneau, Nazzareno Galiè, Pavel Jansa, et al.
Circulation. Heart Failure
|
September 23, 2025
Transpulmonary Proteome Gradients Identify Pathways Involved in Pulmonary Vascular Disease Due To Heart Failure
Vojtech Melenovsky, Petr Jarolim, Eva Kutilkova, et al.
BMC Pulmonary Medicine
|
March 18, 2014
Epidemiology and long-term survival of pulmonary arterial hypertension in the Czech Republic: a retrospective analysis of a nationwide registry
Pavel Jansa, Jiri Jarkovsky, Hikmet Al-Hiti, et al.
The European Respiratory Journal
|
June 27, 2015
Bosentan added to sildenafil therapy in patients with pulmonary arterial hypertension
Vallerie McLaughlin, Richard N Channick, Hossein-Ardeschir Ghofrani, et al.
Pulmonary Circulation
|
August 18, 2025
Predicting Response to Switching From Phosphodiesterase Type 5 Inhibitor to Riociguat in Patients With Pulmonary Arterial Hypertension: Biomarker and Responder Analysis of the RESPITE and REPLACE Studies
James R Klinger, Hikmet Al-Hiti, Sung-A Chang, et al.
Page
of 2